The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Metronomic chemotherapy with capecitabine for metastatic colorectal cancer in very elderly patients

  • Jung, Yun Hwa (Division of Medical Oncology, Department of Internal Medicine, College of Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea) ;
  • Lee, Won Jik (Division of Medical Oncology, Department of Internal Medicine, College of Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea) ;
  • Byeon, Jae Ho (Division of Medical Oncology, Department of Internal Medicine, College of Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea) ;
  • Lee, In Kyu (Department of Surgery, College of Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea) ;
  • Han, Chi Wha (Department of Internal Medicine, Cheju Halla General Hospital) ;
  • Woo, In Sook (Division of Medical Oncology, Department of Internal Medicine, College of Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea)
  • Received : 2015.03.02
  • Accepted : 2015.06.17
  • Published : 2017.09.01
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Dotan E, Browner I, Hurria A, Denlinger C. Challenges in the management of older patients with colon cancer. J Natl Compr Canc Netw 2012;10:213-224. https://doi.org/10.6004/jnccn.2012.0020
  2. Feliu J, Escudero P, Llosa F, et al. Capecitabine as firstline treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study. J Clin Oncol 2005;23:3104-3111. https://doi.org/10.1200/JCO.2005.06.035
  3. Sun W. Evolution of capecitabine dosing in colorectal cancer. Clin Colorectal Cancer 2010;9:31-39. https://doi.org/10.3816/CCC.2010.n.004
  4. Andre N, Carre M, Pasquier E. Metronomics: towards personalized chemotherapy? Nat Rev Clin Oncol 2014;11:413-431. https://doi.org/10.1038/nrclinonc.2014.89
  5. Nannini M, Nobili E, Di Cicilia R, et al. To widen the setting of cancer patients who could benefit from metronomic capecitabine. Cancer Chemother Pharmacol 2009;64:189-193. https://doi.org/10.1007/s00280-009-0930-z

Cited by

  1. Clinical characteristics and treatment propensity in elderly patients aged over 80 years with colorectal cancer vol.33, pp.6, 2018, https://doi.org/10.3904/kjim.2016.181